STML

Stemline Therapeutics, Inc.
STML

Delisted

STML was delisted on the 9th of June, 2020.

92 hedge funds and large institutions have $195M invested in Stemline Therapeutics, Inc. in 2018 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 39 increasing their positions, 19 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.6M
Puts
$2.31M
Net Calls
Net Calls Change

Top Buyers

1 +$9.41M
2 +$2.61M
3 +$2.36M
4
Axa
Axa
France
+$2.18M
5
PC
Pier Capital
Connecticut
+$1.63M

Top Sellers

1 -$15.1M
2 -$6.54M
3 -$4.16M
4
Invesco
Invesco
Georgia
-$1.1M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.01M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$21.9M
2
$19.6M
3
$13.7M
4
$12.5M
5
$11M
6
$10.3M
7
$10.3M
8
$9.81M
9
$7.25M
10
$6.76M
11
$6.75M
12
$6.47M
13
$4.44M
14
$4.37M
15
$4.03M
16
$3.8M
17
$3.75M
18
$3.55M
19
$2.96M
20
$2.9M
21
$2.85M
22
$2.14M
23
$1.85M
24
$1.76M
25
$1.48M